Disc Medicine, Inc.
- Last sale
- Nov 12, 2026 · -4.49%
- Market cap
- $3.79B
- 45.54M shares
- Filings
- 780
—
—
—Q3 2026N/M FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026derivedN/M FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026−52.6% FY25 yoy
- $3.79B
- —
- —
- 6.3×
- -4.79%
- —
FY2025 figures · derived
Price
Nov 12, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Research And Development
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $170,640,000 | reported | |
| FY 2024 | 2024-12-31 | $96,671,000 | reported | |
| FY 2023 | 2023-12-31 | $69,264,000 | reported | |
| FY 2022 | 2022-12-31 | $33,437,000 | reported | |
| FY 2021 | 2021-12-31 | $25,170,000 revised | reported | |
| FY 2020 | 2020-12-31 | $28,170,000 | reported |
Pharmaceutical preparations
Disc Medicine, Inc. is the 62nd largest of the 553 covered companies the SEC files under this code, by market cap. SIC 2834
CompanyRevenueGrowthNet marginMarket cap
XENEXenon Pharmaceuticals Inc.$7.5M—4,612.1%$4.0BABCLAbCellera Biologics Inc.$75.1M160.6%194.9%$3.8B
IRONDisc Medicine, Inc. (this company)———$3.8B
SLNSilence Therapeutics plc$559.0K98.7%15,851.9%$3.7BACADAcadia Pharmaceuticals Inc$1.1B11.9%36.5%$3.7BOGNOrganon & Co.$6.2B2.9%3.0%$3.7BELVNEnliven Therapeutics, Inc.———$3.6BAMLXAmylyx Pharmaceuticals, Inc.$0.0100.0%—$3.5BVKTXViking Therapeutics, Inc.$0.0——$3.5BPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Disc Medicine, Inc. · CIK 1816736 · Engraved from SEC EDGAR